Table 4

Adverse events during 30-day post-procedure period as adjudicated by the Clinical Events Committee (CEC)

CEC-adjudicated eventsResults, n (%)
(N=50)
Serious
 Diplopia1 (2.0%)
 Headache1 (2.0%)
 Retroperitoneal hemorrhage1 (2.0%)
Non-serious
 Access site hematoma1 (2.0%)
 Carotid artery dissection1 (2.0%)
 Cerebral infarction1 (2.0%)
 Nausea2 (4.0%)